Literature DB >> 2843410

Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia.

I Gerling1, C Nejman, N K Chatterjee.   

Abstract

Diabetogenic strains of Coxsackievirus B4 (CB4) produce a diabetes syndrome in susceptible mice that resembles insulin-dependent diabetes mellitus. To assess the possible role of autoimmunity, the expression of a 64,000-Mr islet antigen in SJL/J and CD1 mice infected with a diabetogenic strain of CB4 was monitored in early and late infection. Additionally, virus-induced abnormalities in glucose metabolism were correlated with several changes in purified islets to assess beta-cell physiology. Over 80% of the mice exhibited subnormal blood glucose at 72 h postinfection (p.i.) and were hyperglycemic at 6 and 8 wk p.i. Islet yield in infected mice decreased by 29-47% at 72 h and 6 wk p.i. compared to noninfected mice. Insulin release stimulated by 16.7 mM glucose increased greater than twofold at 72 h p.i. but declined at 6 wk well below the level of noninfected mice. Likewise, residual islet insulin content after release also increased at 72 h and then declined. Total protein synthesis in the islets decreased by 30% at 72 h and by 60% at 6 wk p.i. Although the synthesis of five proteins of heterogeneous molecular weights, including tubulin, was severely depressed in the infected islets at 72 h p.i. compared with control islets or islets at 6 wk p.i., synthesis of the 64,000-Mr component and another protein of 36,000 Mr increased by two- to threefold. It is possible that CB4 infection may initiate or enhance an autoimmune reaction by increased expression of the 64,000-Mr antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843410     DOI: 10.2337/diab.37.10.1419

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

Authors:  D M See; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

2.  Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets.

Authors:  L A Velloso; O Kämpe; D L Eizirik; A Hallberg; A Andersson; F A Karlsson
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

3.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Absence of autoantibodies against glutamate decarboxylase (GAD) in the non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets.

Authors:  L A Velloso; D L Eizirik; F A Karlsson; O Kämpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

5.  Virus-like infection induces human β cell dedifferentiation.

Authors:  Masaya Oshima; Klaus-Peter Knoch; Marc Diedisheim; Antje Petzold; Pierre Cattan; Marco Bugliani; Piero Marchetti; Pratik Choudhary; Guo-Cai Huang; Stefan R Bornstein; Michele Solimena; Olivier Albagli-Curiel; Raphael Scharfmann
Journal:  JCI Insight       Date:  2018-02-08

Review 6.  Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment.

Authors:  Adebola Matthew Giwa; Rizwan Ahmed; Zahra Omidian; Neha Majety; Kagan Ege Karakus; Sarah M Omer; Thomas Donner; Abdel Rahim A Hamad
Journal:  World J Diabetes       Date:  2020-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.